Benazzi Franco
E. Hecker Outpatient Psychiatry Center, Ravenna, Italy.
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1279-85. doi: 10.1016/j.pnpbp.2004.06.018.
The diagnostic validity of agitated depression (AD, a major depressive episode (MDE) with psychomotor agitation) is unclear. It is not classified in DSM-IV and ICD-10 classification of mental and behavioural disorder (ICD-10). Some data support its subtyping. This study aims to test the subtyping of AD.
Consecutive 245 bipolar-II (BP-II) and 189 major depressive disorder (MDD) non-tertiary-care MDE outpatients were interviewed (off psychoactive drugs) with Structured Clinical Interview for DSM-IV Axis I Disorders--Clinician Version (SCID-CV), Hypomania Interview Guide (HIGH-C), and Family History Screen. Intra-MDE hypomanic symptoms were systematically assessed. AD was defined as an MDE with psychomotor agitation. Mixed AD was defined as an MDE with four or more hypomanic symptoms (including agitation).
AD was present in 34.7% of patients. AD was mixed in 70.1% of AD patients. AD, vs. non-AD, had significantly (at alpha = 0.05) lower age at onset, more BP-II, females, atypical depressions, bipolar-I (BP-I) and BP-II family history, and was more mixed; racing/crowded thoughts, irritability, more talkativeness, and risky behaviour were significantly more common. Mixed AD, vs. non-AD, had significantly (at alpha = 0.01) lower age at onset, more intra-MDE hypomanic symptoms, BP-II, females, atypical depressions, BP-II family history, and specific hypomanic symptoms (distractibility, racing thoughts, irritable mood, more talkativeness, risky activities). Mixed AD, vs. non-mixed AD, had significantly more intra-MDE hypomanic symptoms (by definition), more recurrences, and more specific hypomanic symptoms (by definition). Non-mixed AD, vs. non-AD, had significantly more intra-MDE hypomanic symptoms and more talkativeness.
AD was common in non-tertiary-care depression outpatients, supporting its diagnostic utility. AD and many bipolar diagnostic validators were associated, supporting its link with the bipolar spectrum. Mixed AD, but not non-mixed AD, had differences vs. non-AD similar to those of AD, suggesting that psychomotor agitation by itself may not be enough to identify AD as a subtype. Findings seem to support the subtyping of mixed AD. This subtyping may have important treatment impact, as antidepressants alone might increase agitation.
激越性抑郁(AD,一种伴有精神运动性激越的重度抑郁发作(MDE))的诊断效度尚不清楚。它未被纳入《精神疾病诊断与统计手册》第四版(DSM-IV)以及《国际疾病分类》第十版(ICD-10)的精神与行为障碍分类中。一些数据支持对其进行亚型划分。本研究旨在检验AD的亚型划分。
对连续纳入的245例双相II型(BP-II)障碍和189例重度抑郁症(MDD)非三级护理的MDE门诊患者(停用精神活性药物)进行访谈,采用《精神疾病诊断与统计手册》第四版轴I障碍临床定式访谈——临床医生版(SCID-CV)、轻躁狂访谈指南(HIGH-C)以及家族史筛查。系统评估MDE期间的轻躁狂症状。AD被定义为伴有精神运动性激越的MDE。混合性AD被定义为伴有四种或更多轻躁狂症状(包括激越)的MDE。
34.7%的患者存在AD。70.1%的AD患者为混合性AD。与非AD患者相比,AD患者起病年龄显著更低(α = 0.05),BP-II障碍更多,女性更多,非典型抑郁更多,有双相I型(BP-I)和BP-II家族史的更多,且混合性更多;思维奔逸/杂乱、易激惹、话多以及危险行为显著更常见。与非AD患者相比,混合性AD患者起病年龄显著更低(α = 0.01),MDE期间的轻躁狂症状更多,BP-II障碍更多,女性更多,非典型抑郁更多,BP-II家族史更多,且有特定的轻躁狂症状(注意力分散、思维奔逸、情绪易激惹、话多、危险活动)。与非混合性AD患者相比,混合性AD患者MDE期间的轻躁狂症状显著更多(根据定义),复发更多,且特定的轻躁狂症状更多(根据定义)。与非AD患者相比,非混合性AD患者MDE期间的轻躁狂症状更多,话更多。
AD在非三级护理的抑郁症门诊患者中很常见,支持其诊断效用。AD与许多双相障碍的诊断验证指标相关,支持其与双相谱系的联系。与非AD患者相比,混合性AD患者存在差异,而非混合性AD患者与非AD患者相比无类似差异,这表明精神运动性激越本身可能不足以将AD识别为一个亚型。研究结果似乎支持混合性AD的亚型划分。这种亚型划分可能对治疗有重要影响,因为单独使用抗抑郁药可能会加重激越症状。